Clinical application of Xianfang Huoming decoction in hidradenitis suppurativa: a three-case series and literature review
- 1Department of Dermatology, Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine , , ,
- 2Department of Dermatology, Affiliated Hospital of Nanjing University of Chinese Medicine , , ,
Abstract
Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory follicular disease characterized by painful nodules, abscesses, and sinus tract formation that typically affects intertriginous areas, such as the axillae, inguinal regions, and gluteal region. This condition is often persistent and is difficult to control in clinical practice. In recent years, traditional Chinese medicine has been explored as a potential adjunct in its management. Here, we summarize the cases of three male patients with HS treated at the Department of Dermatology, Jiangyin Affiliated Hospital of Nanjing University of Chinese Medicine (2023–2024), aged 12–29 years with disease durations of 6 months to 4 years. The lesions were primarily located in the axillae or gluteal region and presented as recurrent papules, pustules, nodules, and painful cysts. All cases were Hurley stage I–II and classified as heat-toxin accumulation syndrome in traditional Chinese medicine. All patients received individualized combination therapies incorporating Xianfang Huoming Decoction, along with topical treatments, antibiotics, and/or surgical intervention when indicated. After 1–5 weeks of treatment, the inflammatory lesions and pain symptoms improved, with IHS4 scores decreasing by approximately 71%–81%. Patient 1 subsequently experienced recurrence after treatment discontinuation and was lost to dermatological follow-up. These cases suggest that Xianfang Huoming Decoction may help reduce inflammatory activity and promote lesion resolution in HS, supporting its potential role as an adjunctive therapeutic option.
Related
- Hidradenitis Suppurativa from Preconception to Lactation: Clinical Treatment Decision-Making Review
- Comparison of Clinical and Ultrasonographic Severity Assessment in Hidradenitis Suppurativa: Prognostic Implications.
- Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study
- Male-predominant, perianal-prone hidradenitis suppurativa in China: A cohort study of 614 patients.
- Real-world patient journey and unmet needs of people with hidradenitis suppurativa: Social media research in China.
BibTeX
@article{wang2026clinical,
title = {{Clinical application of Xianfang Huoming decoction in hidradenitis suppurativa: a three-case series and literature review}},
author = {Zixi Wang and Xuling Wu and Hongliu Zhu and Ke Liu and Yihong Gao and Yuegang Wei and Qiuxia Mao and Liyan Zhou},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1899685},
url = {https://europepmc.org/article/PMC/PMC13721285},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical application of Xianfang Huoming decoction in hidradenitis suppurativa: a three-case series and literature review
AU - Zixi Wang
AU - Xuling Wu
AU - Hongliu Zhu
AU - Ke Liu
AU - Yihong Gao
AU - Yuegang Wei
AU - Qiuxia Mao
AU - Liyan Zhou
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1899685
UR - https://europepmc.org/article/PMC/PMC13721285
AB - Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory follicular disease characterized by painful nodules, abscesses, and sinus tract formation that typically affects intertriginous areas, such as the axillae, inguinal regions, and gluteal region. This condition is often persistent and is difficult to control in clinical practice. In recent years, traditional Chinese medicine has been explored as a potential adjunct in its management. Here, we summarize the cases of three male patients with HS treated at the Department of Dermatology, Jiangyin Affiliated Hospital of Nanjing University of Chinese Medicine (2023–2024), aged 12–29 years with disease durations of 6 months to 4 years. The lesions were primarily located in the axillae or gluteal region and presented as recurrent papules, pustules, nodules, and painful cysts. All cases were Hurley stage I–II and classified as heat-toxin accumulation syndrome in traditional Chinese medicine. All patients received individualized combination therapies incorporating Xianfang Huoming Decoction, along with topical treatments, antibiotics, and/or surgical intervention when indicated. After 1–5 weeks of treatment, the inflammatory lesions and pain symptoms improved, with IHS4 scores decreasing by approximately 71%–81%. Patient 1 subsequently experienced recurrence after treatment discontinuation and was lost to dermatological follow-up. These cases suggest that Xianfang Huoming Decoction may help reduce inflammatory activity and promote lesion resolution in HS, supporting its potential role as an adjunctive therapeutic option.
SN - 2296-858X
ER -